SCHEMBL5835243

SCHEMBL5835243

CCN(CC)c1ccc(NC(=O)C2(NC(=O)OCC(C)C)CCc3cc(OC)ccc3C2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.78
KCNH2 Q12809 1/20 0.50
MAPT P10636 4/20 0.39
FAAH O00519 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
GFER P55789 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CXCR5 P32302 2/20 0.36
POLB P06746 2/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
NAMPT P43490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835656 1.00 GHSR (0.78) GHSRKCNH2MAPTFAAHTRPV1
SCHEMBL5835380 0.89 GHSR (0.79) GHSRKCNH2MAPTFAAHTRPV1
SCHEMBL5835476 0.89 GHSR (0.79) GHSRKCNH2MAPTFAAHTRPV1
SCHEMBL5835139 0.88 GHSR (1.00) GHSRKCNH2MAPTSMN1; SMN2ALDH1A1
SCHEMBL5834757 0.84 GHSR (0.71) GHSRKCNH2MAPTSMN1; SMN2ALDH1A1
SCHEMBL5835325 0.84 GHSR (0.71) GHSRKCNH2MAPTSMN1; SMN2ALDH1A1
SCHEMBL5835065 0.82 GHSR (0.80) GHSRKCNH2MAPTFAAHTRPV1
SCHEMBL5835522 0.82 GHSR (0.49) GHSRMAPTSMN1; SMN2GAAL3MBTL1
SCHEMBL5835625 0.80 GHSR (1.00) GHSRKCNH2MAPT
SCHEMBL5836504 0.80 GHSR (1.00) GHSRKCNH2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885KCNH2 3931/4885MAPT 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.